Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,896,167
+$6,357,371 QoQ
Shares Held
143,760
+931.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 82.50626043405677.ToString("F0")%
Shared 0.ToString("F0")%
None 17.49373956594324.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. RPRX ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,502 | $29,748,185 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,092 | $14,330,361 | |
| 3 | EXEL |
Exelixis, Inc.
|
312,296 | $13,394,375 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
121,088 | $7,825,917 | |
| 5 | CELC |
Celcuity Inc.
|
61,068 | $6,970,301 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
143,760 | $6,896,167 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
29,900 | $5,969,535 | |
| 8 | INCY |
Incyte Corp
|
53,555 | $5,040,596 |
All Filings in RPRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,896,167 | 143,760 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $538,796 | 13,944 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $416,833 | 11,815 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $454,446 | 12,613 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $376,268 | 12,087 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $378,287 | 14,829 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $829,689 | 29,328 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $815,465 | 30,924 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,016,149 | 33,459 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,096,858 | 39,048 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,544,808 | 56,920 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,895,582 | 61,665 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,220,853 | 61,639 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,594,013 | 65,638 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,577,707 | 64,154 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $12,107 | 288 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $10,090 | 259 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,857 | 147 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,480 | 207 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $286 | 7 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||